InnovAge Holding Corp. (INNV) stock
INNVNasdaqServices-Health ServicesFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 12/3056% above fair value
$8.91+0.00 (0.00%)
Close on Nov 19, 2026Market cap $1.22BP/E –Yield –
InnovAge free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
InnovAge's free cash flow for the twelve months ending Jun 30, 2026 was $50.41M, up 89.5% year over year. For fiscal 2026 it was $50.41M, up 89.5% from the year before. The highest annual figure on record is $50.41M in fiscal 2026.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $50.41M | +89.5% |
| FY2025 | Jun 30, 2025 | $26.60M | – |
| FY2024 | Jun 30, 2024 | -$44.81M | – |
| FY2023 | Jun 30, 2023 | -$3.12M | – |
| FY2022 | Jun 30, 2022 | -$10.94M | – |
| FY2021 | Jun 30, 2021 | -$25.09M | -178.4% |
| FY2020 | Jun 30, 2020 | $31.98M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | $17.02M | +85.4% |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | $14.54M | -33.1% |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | $19.00M | +251.2% |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | -$153.00K | – |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | $9.18M | – |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | $21.73M | +611.0% |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | $5.41M | – |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | -$9.72M | – |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | -$1.43M | -115.7% |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | $3.06M | -87.5% |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | -$10.88M | – |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | -$35.56M | -751.1% |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $9.13M | – |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | $24.38M | – |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | -$42.08M | -1868.9% |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | $5.46M | -68.8% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | -$14.85M | -346.7% |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | -$15.98M | – |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | $2.38M | -77.3% |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | $17.52M | – |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $6.02M | -71.4% |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | -$18.90M | – |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $10.48M | – |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | -$22.69M | – |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $21.05M | – |
See a number that looks wrong?